glp-1 colorectal cancer mortality study november 2025 ASCO 2026: Receptor Agonists May Reduce in Patients With Frontiers | BTBD19 promotes colorectal

In addition, if a patient presents with nausea, vomiting, or abdominal pain, surgery should be postponed

Medicines with a narrow therapeutic index may require additional monitoring, and warfarin may require more frequent INR monitoring when initiating GLP-1 therapy

K., Zeyda, M., Prager, G

For researchers studying tissue repair and regeneration , this anti-fibrotic activity is particularly relevant because fibrosis (excessive scar tissue formation) is often the limiting factor in functional recovery

When you know how to recognize common side effects, when to check in, and how to keep everything on track, your experience becomes a lot smoother